Exagen Inc. (NASDAQ:XGN) Given Average Recommendation of "Moderate Buy" by Analysts
Exagen Inc. (NASDAQ:XGN - Get Free Report) has been given an average recommendation of "Moderate Buy" by the ten research firms that are covering the stock, MarketBeat.com reports. One analyst has rated the stock with a sell rating and nine have issued a buy rating on the company. The average 1...
MarketBeat·2d ago
More News
Exagen (NASDAQ:XGN) Cut to "Sell" at Wall Street Zen
Wall Street Zen downgraded shares of Exagen from a "hold" rating to a "sell" rating in a report on Sunday...
MarketBeat·7d ago
Exagen Inc. (NASDAQ:XGN) Short Interest Update
Exagen Inc. (NASDAQ:XGN - Get Free Report) was the target of a large increase in short interest in March. As of March 31st, there was short interest totaling 1,534,970 shares, an increase of 34.3...
MarketBeat·11d ago
Exagen (NASDAQ:XGN) Stock Rating Upgraded by Wall Street Zen
Wall Street Zen raised Exagen from a "sell" rating to a "hold" rating in a research report on Saturday...
MarketBeat·15d ago
Exagen Inc. (NASDAQ:XGN) Given Average Recommendation of "Moderate Buy" by Brokerages
Exagen Inc. (NASDAQ:XGN - Get Free Report) has earned an average rating of "Moderate Buy" from the ten analysts that are covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation and nine have assigned a buy recommendation to the compan...
MarketBeat·27d ago
Exagen Inc. (NASDAQ:XGN) Short Interest Update
Exagen Inc. (NASDAQ:XGN - Get Free Report) was the recipient of a large increase in short interest in the month of February. As of February 27th, there was short interest totaling 1,071,934 shares...
MarketBeat·1mo ago
Exagen (NASDAQ:XGN) Downgraded by Wall Street Zen to Sell
Wall Street Zen cut Exagen from a "hold" rating to a "sell" rating in a report on Saturday...
MarketBeat·1mo ago
Canaccord Genuity Group Issues Pessimistic Forecast for Exagen (NASDAQ:XGN) Stock Price
Canaccord Genuity Group dropped their price objective on shares of Exagen from $15.00 to $10.00 and set a "buy" rating on the stock in a report on Wednesday...
MarketBeat·2mo ago
Exagen (NASDAQ:XGN) Price Target Cut to $10.00 by Analysts at Craig Hallum
Craig Hallum decreased their price objective on shares of Exagen from $12.00 to $10.00 and set a "buy" rating for the company in a research report on Wednesday...
MarketBeat·2mo ago
KeyCorp Issues Pessimistic Forecast for Exagen (NASDAQ:XGN) Stock Price
KeyCorp cut their price target on Exagen from $15.00 to $10.00 and set an "overweight" rating for the company in a research note on Wednesday...